Related Experiment Videos
Mechanisms of the mAb ALB6(CD9) induced human platelet activation: comparison with thrombin
Abstract:
A CD9 monoclonal antibody described to aggregate human platelets was studied on different platelet functions in order to determine its mechanism of action. After a lag phase of 35 sec the mAb ALB6 induced a transient decrease in 32P-polyphosphoinositides, synthesis of 32P-phosphatidate (PA), phosphorylation of myosin light chain (P20) and of 43 KDa protein (P43) and the release reaction. Final biological and metabolic effects of ALB6 thus appear similar to that of thrombin but three differences bring additional information: (i) the lag phase, (ii) the kinetic of ALB6-induced release is identical for all granules whereas the release of dense granules is faster when induced by thrombin. (iii) no external Ca++ is required for ALB6 induced-activation.
Insights
A CD9 monoclonal antibody (mAb ALB6) activates human platelets, mimicking thrombin but with unique characteristics. It triggers signaling pathways and granule release without requiring external calcium ions.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- CD9 monoclonal antibodies are known to aggregate human platelets.
- Understanding the precise mechanism of CD9-mediated platelet activation is crucial.
Purpose of the Study:
- To elucidate the mechanism of action of the CD9 monoclonal antibody ALB6 on human platelet functions.
- To compare ALB6-induced platelet activation with thrombin-induced activation.
Main Methods:
- Studied various platelet functions following stimulation with mAb ALB6.
- Monitored 32P-polyphosphoinositides, 32P-phosphatidate (PA) synthesis, and protein phosphorylation (myosin light chain P20, 43 KDa protein P43).
- Assessed the release reaction from platelet granules.
Main Results:
- mAb ALB6 induced a transient decrease in 32P-polyphosphoinositides, synthesis of 32P-PA, and phosphorylation of P20 and P43 after a 35-sec lag phase.
- The release reaction kinetics for all granules were identical with ALB6, unlike thrombin where dense granule release is faster.
- ALB6-induced platelet activation did not require external calcium ions (Ca++).
Conclusions:
- The biological and metabolic effects of mAb ALB6 on platelets are similar to thrombin.
- Key differences, including a lag phase, uniform granule release kinetics, and calcium independence, distinguish ALB6-mediated activation.
- These findings provide novel insights into CD9-dependent platelet activation pathways.